randomized study

Article

randomized study

Luis Ruilope,Markolf Hanefeld,A Michael Lincoff,Giancarlo Viberti,Sylvie Meyer-reigner,Nadejda Mudie+3 more-2010-01-01

0

TL;DRAbstract

Effects of the dual peroxisome proliferator-onist aleglitazar on glomerular filtration rate versus 5.4 % with pioglitazone at end of treatment, which plateaued to 8 weeks and was not progressive. Superior improvements in high-density lipoprotein cholesterol, low-density lipoprotein cholesterol and Ruilope et al. BMC Nephrology 2014, 15:180

Chat with Paper

AI Agents for this Paper

Effects of the dual peroxisome proliferator-onist aleglitazar on glomerular filtration rate versus 5.4 % with pioglitazone at end of treatment, which plateaued to 8 weeks and was not progressive. Superior improvements in high-density lipoprotein cholesterol, low-density lipoprotein cholesterol and Ruilope et al. BMC Nephrology 2014, 15:180

Keywords

Pioglitazone Nephrology Lipoprotein Renal function Randomized controlled trial Lipoprotein(a)Cholesterol Low-density lipoprotein

Chat

Click to start Chat